Clinical Trial Update: Clinical and Genomic Responses to Open Heart Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting clinical and genomic responses to open heart surgery in ischemia-reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Ischemia-reperfusion (IR) Injury | Phase 3 | Status: COMPLETED